Aspiration Thrombectomy and Drug-Eluting Stent Implantation Decrease the Occurrence of Angina Pectoris One Year After Acute Myocardial Infarction

AbstractAngina pectoris is a treatable symptom that is associated with mortality and decreased quality of life. Angina eradication is a primary care goal of care after an acute myocardial infarction (AMI). Our aim was to evaluate factors influencing angina pectoris 1 year after an AMI.From January 2005 to December 2013, 1547 patient received primary percutaneous intervention in our hospital for an acute ST-segment elevation myocardial infarction (MI). Of these patients, 1336 patients did not experience post-MI angina during a 1-year follow-up, and 211 patients did. Univariate and multivariate logistic regression analyses were performed to identify the factors influencing angina pectoris 1 year after an AMI. Propensity score matched analyses were performed for subgroups analyses.The average age of the patients was 61.08 ± 12.77 years, with a range of 25 to 97 years, and 82.9% of the patients were male. During 1-year follow-up, 13.6% of the patients experienced post-MI angina. There was a longer chest pain-to-reperfusion time in the post-MI angina group (P = 0.01), as well as a higher fasting sugar level, glycohemoglobin (HbA1C), serum creatinine, troponin-I and creatine kinase MB (CK-MB). The post-MI angina group also had a higher prevalence of multiple-vessel disease. Manual thrombectomy, and distal protective device and intracoronary glycoprotein IIb/IIIa inhibitor injection were used frequently in the no post-MI angina group. Antiplatelet agents and post-MI medication usage were similar between the 2 groups. Multivariate logistic regression analyses demonstrated that prior MI was a positive independent predictor of occurrence of post-MI angina. Manual thrombectomy use and drug-eluting stent implantation were negative independent predictors of post-MI angina. Higher troponin-I and longer chest pain-to-reperfusion time exhibited a trend toward predicting post-MI angina.Prior MIs were strong, independent predictors of post-MI angina. Manual thrombectomy and drug-eluting stent implantation could decrease the occurrence of angina pectoris 1 year after an AMI, decrease long-term healthy costs, and increase post-MI quality of life.

[1]  H. Yip,et al.  Comparison of different strategies for acute ST-segment elevation myocardial infarction with high thrombus burden in clinical practice: Symptom-free outcome at one year. , 2015, Heart & lung : the journal of critical care.

[2]  J. Spertus,et al.  Risk Factors for Rehospitalization for Acute Coronary Syndromes and Unplanned Revascularization Following Acute Myocardial Infarction , 2015, Journal of the American Heart Association.

[3]  I. Kurkowska-Jastrzębska,et al.  Application of microRNAs in diagnosis and treatment of cardiovascular disease , 2015, Acta physiologica.

[4]  E. Omerovic,et al.  Outcomes 1 year after thrombus aspiration for myocardial infarction. , 2014, The New England journal of medicine.

[5]  T. Tuschl,et al.  A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. , 2014, The Journal of clinical investigation.

[6]  V. Menon,et al.  Faculty Opinions recommendation of 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013 .

[7]  M. Jeong,et al.  Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. , 2013, International journal of cardiology.

[8]  David Erlinge,et al.  Thrombus aspiration during ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.

[9]  H. Suryapranata,et al.  A meta-analytic overview of thrombectomy during primary angioplasty. , 2013, International journal of cardiology.

[10]  P. Serruys,et al.  Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study--TROFI trial. , 2013, European heart journal.

[11]  B. Trimarco,et al.  G-Protein-Coupled Receptor Kinase 2 and Hypertension , 2013, High Blood Pressure & Cardiovascular Prevention.

[12]  G. Stone Simple aspiration in acute myocardial infarction: too simple to be true? , 2012, European heart journal.

[13]  D. Atar,et al.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. , 2012, European heart journal.

[14]  G. Condorelli,et al.  CaMK4 Gene Deletion Induces Hypertension , 2012, Journal of the American Heart Association.

[15]  C. Tei,et al.  Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. , 2011, Journal of cardiology.

[16]  Jung‐Sun Kim,et al.  Drug-eluting stents versus bare-metal stents in acute myocardial infarction: A systematic review and meta-analysis , 2011, International Journal of Technology Assessment in Health Care.

[17]  M. Chiariello,et al.  The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events , 2010, BMC cardiovascular disorders.

[18]  Harlan M Krumholz,et al.  National Patterns of Risk-Standardized Mortality and Readmission for Acute Myocardial Infarction and Heart Failure: Update on Publicly Reported Outcomes Measures Based on the 2010 Release , 2010, Circulation. Cardiovascular quality and outcomes.

[19]  J. Jakowitsch,et al.  Long‐term outcome after thrombectomy in acute myocardial infarction , 2010, European journal of clinical investigation.

[20]  M. Chiariello,et al.  Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  S. Normand,et al.  Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. , 2009, JAMA.

[22]  H. Krumholz,et al.  Angina at 1 year after myocardial infarction: prevalence and associated findings. , 2008, Archives of internal medicine.

[23]  H. Yip,et al.  Six‐month angiographic results of primary angioplasty with adjunctive PercuSurge GuardWire device support: Evaluation of the restenotic rate of the target lesion and the fate of the distal balloon occlusion site , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  Á. Avezum,et al.  A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. , 2004, Journal of the American Medical Association (JAMA).

[25]  H. Yip,et al.  Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. , 2003, Chest.

[26]  E W Steyerberg,et al.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.

[27]  S. Pocock,et al.  Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial‡☆ , 2000 .

[28]  MichaelHaude,et al.  Nonischemic Chest Pain Induced by Coronary Interventions , 1998 .

[29]  A. Jeremias,et al.  Nonischemic chest pain induced by coronary interventions: a prospective study comparing coronary angioplasty and stent implantation. , 1998, Circulation.

[30]  W. Kannel,et al.  Epidemiologic assessment of angina before and after myocardial infarction: The Framingham study. , 1996, American heart journal.

[31]  D. Baim,et al.  Frequency and outcome of chest pain after two new coronary interventions (atherectomy and stenting). , 1992, The American journal of cardiology.

[32]  M. Stadius,et al.  Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis. , 1988, Circulation.

[33]  B. Meier,et al.  Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach. , 1983, Circulation.

[34]  H. Krumholz,et al.  Angina at 1 Year After Myocardial Infarction , 2016 .

[35]  K. Mahaffey,et al.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .

[36]  K. Mahaffey,et al.  Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC ) , 2012 .

[37]  G. Moneta Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction , 2009 .

[38]  S. Rinfret,et al.  Thrombus aspiration during primary percutaneous coronary intervention. , 2008, The New England journal of medicine.

[39]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi , 2004, The Canadian journal of cardiology.